Press release
Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Pfizer Inc., Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Novartis AG, Sanofi S.A.,
Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Size
The Business Research Company offers in-depth market insights through Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.
Market Size And Growth Forecast:
The exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market size has grown strongly in recent years. It will grow from $5.24 billion in 2023 to $5.69 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increased prevalence of underlying conditions, advancements in diagnostic tools, pharmaceutical developments, rising global healthcare access.
The exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $7.67 billion in 2028 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to telemedicine and remote monitoring, data analytics and ai, patient education and support, regulatory changes and reimbursement policies. Major trends in the forecast period include personalized treatment approaches, development of novel therapies, minimally invasive diagnostics, collaborative care models.
Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=12992&type=smp
Market Segmentation:
The main types of therapies included in exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics are nutritional management, pancreatic enzyme replacement therapy (PERT) and lifestyle modifications approach. Nutritional management is a specialized approach to healthcare that involves the use of nutrition and diet to treat and manage various medical and health conditions. Various types of diagnostics are involved, including blood tests, magnetic resonance imaging (MRI), endoscopic ultrasonography (EUS) and computerized tomography (CT) scanning. Several types of drugs are used, such as generic and branded, which are sold through various distribution channels, including direct tender, retail pharmacy, third-party distributor and others and are used by various end users, such as hospitals, specialty clinics, homecare, diagnostic centers, research and academic institutes and others.
Major Driver - Rising Diabetes Prevalence Fuels Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market
The increasing number of people with diabetes is expected to propel the growth of the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market going forward. Diabetes refers to a chronic metabolic disorder characterized by high blood sugar levels (hyperglycemia) over a prolonged period. This condition results from the body's inability to produce enough insulin or effectively use the insulin it produces. EPI therapy, which involves pancreatic enzyme replacement therapy (PERT), can help improve nutrient absorption in people with diabetes and EPI. It can also help improve glycemic control in people with diabetes. For instance, in November 2021, according to the International Diabetes Federation, a Belgium-based umbrella organization of over 230 national diabetes associations, approximately 537 million adults (20-79 years old) were living with diabetes in 2021, whereas the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Therefore, the increasing number of people with diabetes is driving the growth of the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market.
Competitive Landscape:
Major players in the exocrine pancreatic insufficiency (epi) therapeutics and diagnostics market are Pfizer Inc., Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Novartis AG, Sanofi S.A., AstraZeneca PLC, Abott Laboratories, Medtronic PLC, Solvay S.A., Laboratory Corporation of America Holdings (Labcorp), Organon group of companies Metagenics LLC, Allergan PLC, Chiesi Farmaceutici S.p.A., Codexis Inc., Nordmark Arzneimittel GmbH & Co. KG, ChiRhoClin Inc., Digestive Care Inc., Alcresta Therapeutics Inc., Vivus Inc., Cilian AG, Bioserv Diagnostics Gmbh, Anthera Pharmaceuticals Inc., Aptalis Pharma Inc., First Wave BioPharma Inc., EagleBiosciences Inc., ScheBo Biotech AG.
Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/exocrine-pancreatic-insufficiency-epi-therapeutics-and-diagnostics-global-market-report
Top Trend - Innovative Studies And Solutions Drive Advancements In The Epi Therapeutics And Diagnostics Market
Major companies operating in the exocrine pancreatic insufficiency (EPI) therapeutics and diagnostics market are focused on innovating new studies and solutions, such as PACT-CP to sustain their position in the market. For instance, in June 2021, Aimmune Therapeutic, a US-based biopharmaceutical company, launched PACT-CP, a patient-centric chronic pancreatitis registry study, to better understand the unmet needs and therapeutic burden on patients with EPI due to chronic pancreatitis (CP). It is the first real-world registry study for patients with chronic pancreatitis. The study, which will follow about 400 patients at 20 gastroenterology facilities across the United States, was created with the help of patients and expert consultants. The PACT-CP Registry study is a prospective, non-interventional research study for patients receiving gastroenterology treatment diagnosed with EPI due to chronic pancreatitis.
The Table Of Content For The Market Report Include:
1. Executive Summary
2. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Characteristics
3. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Trends And Strategies
4. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market - Macro Economic Scenario
5. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Size And Growth
…..
27. Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exocrine Pancreatic Insufficiency (EPI) Therapeutics And Diagnostics Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Pfizer Inc., Merck & Co. Inc., Janssen Pharmaceuticals Inc., AbbVie Inc., Novartis AG, Sanofi S.A., here
News-ID: 3404344 • Views: …
More Releases from The Business research company
Assessing Liquid Applied Membranes Market Demand and Segments: Insights into Ind …
The liquid applied membranes market size has grown strongly in recent years. It will grow from $18.89 billion in 2023 to $20.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to infrastructure development, waterproofing requirements, increased construction activities, awareness of building envelope integrity, expansion of commercial and industrial sectors.
The liquid applied membranes market size is…
InsurTech (Insurance Technology) Market Size and Forecast 2033: Analyzing Growth …
The insurtech (insurance technology) market size has grown exponentially in recent years. It will grow from $14.37 billion in 2023 to $19.58 billion in 2024 at a compound annual growth rate (CAGR) of 36.2%. The growth in the historic period can be attributed to digital transformation in insurance, risen consumer expectations, data analytics and risk assessment, regulatory changes and compliance, emergence of insurtech startups.
The insurtech (insurance technology) market…
In Situ Hybridization Market Anticipated to Experience Robust Growth Due to Risi …
The in situ hybridization market size has grown strongly in recent years. It will grow from $1.57 billion in 2023 to $1.72 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to early adoption in research, evolution of molecular biology tools, diagnostic applications development, shift in biomedical research focus, increasing investment in biotechnology..
The in situ hybridization…
Global HPV Testing And Pap Test Market Expected to Witness Significant Growth, D …
The hpv testing and pap test market size has grown rapidly in recent years. It will grow from $4.08 billion in 2023 to $4.52 billion in 2024 at a compound annual growth rate (CAGR) of 10.7%. The growth in the historic period can be attributed to cervical cancer awareness campaigns, screening program implementations, government initiatives and funding, women's health advocacy, increased disease burden, gynecological examination practices.
The hpv testing…
More Releases for EPI
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
Global Epi Wafer Market 2018 - Nichia, EpiWorks, Norstel, OMMIC
Eminent Market, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on…
Epitaxial (Epi) Wafer Market Investment Research Report 2025
Epitaxy is a method used to grow or lay a single crystalline film or layer over a crystalline-based semiconductor surface or substrate. The deposited substance must have a definite acclimatization with regard to the crystal-based semiconductor substrate. Moreover, Chip developers applies either molten or vapor based foundations to produce such epitaxial over layers. An epitaxial wafer is a wafer of semiconducting substrate made by epitaxial growth for application in microelectronics,…
Global Epi Wafer Market Report Analysis and Forecast 2017
ReportsWeb.com has announced the addition of the “Global Epi Wafer Market Research Report 2017-2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification.
The Global Epi Wafer Market Professional Survey Report 2017 is a professional and in-depth study on the current state of the Epi Wafer market. Annual estimates and forecasts are provided for the period 2017 through 2022. Also, a…
Epi Wafer Market 2017 - GlobalWafers, Nichia, EpiWorks
Apex Research, recently published a detailed market research study focused on the "Epi Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epi Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epi Wafer industry, and estimates the future trend of Epi Wafer market on…
Epitaxial (Epi) Wafer Market 2017- ASM International, EpiWorks, Jenoptik
Marketreports.biz, recently published a detailed market research study focused on the "Epitaxial (Epi) Wafer Market" across the global, regional and country level. The report provides 360° analysis of "Epitaxial (Epi) Wafer Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epitaxial (Epi) Wafer industry, and estimates the future trend of Epitaxial…
